1326244-85-2Relevant academic research and scientific papers
Pyrimethamine Derivatives: Insight into Binding Mechanism and Improved Enhancement of Mutant β- N -acetylhexosaminidase Activity
Tropak, Michael B.,Zhang, Jianmin,Yonekawa, Sayuri,Rigat, Brigitte A.,Aulakh, Virender S.,Smith, Matthew R.,Hwang, Hee-Jong,Ciufolini, Marco A.,Mahuran, Don J.
, p. 4483 - 4493 (2015/06/23)
In order to identify structural features of pyrimethamine (5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine) that contribute to its inhibitory activity (IC50 value) and chaperoning efficacy toward β-N-acetylhexosaminidase, derivatives of the compound were synthesized that differ at the positions bearing the amino, ethyl, and chloro groups. Whereas the amino groups proved to be critical to its inhibitory activity, a variety of substitutions at the chloro position only increased its IC50 by 2-3-fold. Replacing the ethyl group at the 6-position with butyl or methyl groups increased IC50 more than 10-fold. Surprisingly, despite its higher IC50, a derivative lacking the chlorine atom in the para-position was found to enhance enzyme activity in live patient cells a further 25% at concentrations >100 μM, while showing less toxicity. These findings demonstrate the importance of the phenyl group in modulating the chaperoning efficacy and toxicity profile of the derivatives.
COMPOUNDS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES
-
Page/Page column 14; 15, (2011/08/22)
A method of treating a lysosomal storage disease comprises administering a pyrimethamine derivative to a subject in need thereof.
